台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣拜耳股份有限公司 台北市信義區信義路五段7號台北101大樓之53至54樓 (23167184) - disodium clodronate (tetrahydrate) - 注射劑 - disodium clodronate (tetrahydrate) (6400091410) mg - clodronic acid - 惡性腫瘤之蝕骨性骨頭轉移，惡性高血鈣症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣拜耳股份有限公司 台北市信義區信義路5段7號53樓 (23167184) - disodium clodronate (tetrahydrate) - 膠囊劑 - disodium clodronate (tetrahydrate) (6400091410) mg - clodronic acid - 惡性腫瘤之蝕骨性骨頭轉栘，惡性高血鈣症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - l-isoleucine;;l-leucine;;lysine l- (hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-aspartic acid;;asparagine l- monohydrate (eq to asparagine h2o l- );;acetylcysteine;;l-cysteine;;glutamic acid l-;;l-ornithine hcl;;l-serine;;tyrosine l-(n-acetyl);;l-tyrosine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium acetate;;magnesium acetate tetrahydrate;;sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate);;malic acid l-;;sodium hydroxide;;edetate disodium dihydrate (eq to disodium edetate dihydrate) - 注射劑 - potassium acetate (4008000100) 2.45gm; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 3.95gm; magnesium acetate tetrahydrate (4012001450) 0.56gm; l-alanine (4020100202) 13.70gm; l-arginine (4020100302) 9.20gm; l-aspartic acid (4020100402) 1.30gm; asparagine l- monohydrate (eq to asparagine h2o l- ) (4020100472) (3.72g) 3.27gm; l-cysteine (4020100502) 0.50gm; glutamic acid l- (4020100702) 4.60gm; l-histidine (4020100902) 5.20gm; l-isoleucine (4020101002) 5.10gm; l-leucine (4020101202) 8.90gm; l-methionine (4020101502) 3.80gm; l-ornithine hcl (4020101612) (3.20g) 2.5gm; l-phenylalanine (4020101702) 5.10gm; l-proline (4020101802) 8.90gm; l-serine (4020101902) 2.40gm; l-threonine (4020102002) 4.10gm; l-tryptophan (4020102102) 1.80gm; l-tyrosine (4020102202) 0.30gm; l-valine (4020102302) 4.80gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 7.90gm; lysine l- (hcl) (4020191312) (7.00g) 5.6gm; tyrosine l-(n-acetyl) (4020192212) (1.23g) 1.00gm; acetylcysteine (4800000100) 0.68gm; sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate) (5612002610) 1.40gm; edetate disodium dihydrate (eq to disodium edetate dihydrate) (6400000315) 0.050gm; malic acid l- (9600017802) 1.01gm; sodium hydroxide (9600028200) 0.20gm - amino acids - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能或合成利用障礙、嚴重創傷火傷骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

杏輝藥品工業股份有限公司 宜蘭縣冬山鄉中山村中山路84、84之4、84之6、84之7號、冬山鄉中山村新寮路95、95之1、100之7、100之13、100之15、100之16、103、136號 (42042734) - disodium clodronate (tetrahydrate) - 膠囊劑 - disodium clodronate (tetrahydrate) (6400091410) (400)mg - clodronic acid - 惡性腫瘤之蝕骨性骨頭轉移，惡性高血鈣症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - l-isoleucine;;l-leucine;;lysine l- hcl ( eq to l-lysine hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;asparagine l- monohydrate (eq to asparagine h2o l- );;acetylcysteine;;l-aspartic acid;;glutamic acid l-;;l-ornithine hcl;;l-serine;;l-tyrosine;;tyrosine l-(n-acetyl);;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium acetate;;magnesium acetate tetrahydrate;;sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate);;sodium hydroxide;;malic acid l- - 注射劑 - potassium acetate (4008000100) 2.45mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 3.95mg; magnesium acetate tetrahydrate (4012001450) 0.56mg; l-alanine (4020100202) 6.85mg; l-arginine (4020100302) 4.6mg; l-aspartic acid (4020100402) 0.65mg; asparagine l- monohydrate (eq to asparagine h2o l- ) (4020100472) 1.86mg; glutamic acid l- (4020100702) 2.30mg; l-histidine (4020100902) 2.6mg; l-isoleucine (4020101002) 2.55mg; l-leucine (4020101202) 4.45mg; lysine l- hcl ( eq to l-lysine hcl) (4020101312) 3.5mg; l-methionine (4020101502) 1.9mg; l-ornithine hcl (4020101612) 1.60mg; l-phenylalanine (4020101702) 2.55mg; l-proline (4020101802) 4.45mg; l-serine (4020101902) 1.20mg; l-threonine (4020102002) 2.05mg; l-tryptophan (4020102102) 0.9mg; l-tyrosine (4020102202) 0.30mg; l-valine (4020102302) 2.4mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 3.95mg; tyrosine l-(n-acetyl) (4020192212) 0.43mg; acetylcysteine (4800000100) 0.34mg; sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate) (5612002610) 1.40mg; malic acid l- (9600017802) 1.01mg; sodium hydroxide (9600028200) 0.20mg - amino acids - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能或合成利用障礙、嚴重創傷骨折時蛋白質之補給、蛋白質攝取減少之營養失調症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

雅基利股份有限公司 台北市忠孝東路一段１１２號５樓 (11725213) - l-isoleucine;;l-leucine;;lysine l- (hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-aspartic acid;;asparagine l- monohydrate (eq to asparagine h2o l- );;acetylcysteine;;l-cysteine;;glutamic acid l-;;l-ornithine hcl;;l-serine;;l-tyrosine;;sodium acetate;;potassium acetate;;magnesium acetate tetrahydrate;;sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate);;malic acid l-;;sodium hydroxide;;edetate disodium dihydrate (eq to disodium edetate dihydrate) - 注射劑 - potassium acetate (4008000100) 2.454gm; sodium acetate (4008000600) 3.95gm; magnesium acetate tetrahydrate (4012001450) 0.558gm; l-alanine (4020100202) 13.70gm; l-arginine (4020100302) 9.20gm; l-aspartic acid (4020100402) 1.30gm; asparagine l- monohydrate (eq to asparagine h2o l- ) (4020100472) (3.72g) 3.27gm; l-cysteine (4020100502) 0.50gm; glutamic acid l- (4020100702) 4.60gm; l-histidine (4020100902) 5.20gm; l-isoleucine (4020101002) 5.10gm; l-leucine (4020101202) 8.90gm; l-methionine (4020101502) 3.80gm; l-ornithine hcl (4020101612) (3.20g) 2.5gm; l-phenylalanine (4020101702) 5.10gm; l-proline (4020101802) 8.90gm; l-serine (4020101902) 2.40gm; l-threonine (4020102002) 4.10gm; l-tryptophan (4020102102) 1.80gm; l-tyrosine (4020102202) 0.30gm; l-valine (4020102302) 4.80gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 7.90gm; lysine l- (hcl) (4020191312) (7.00g) 5.6gm; acetylcysteine (4800000100) 0.68gm; sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate) (5612002610) 1.404gm; edetate disodium dihydrate (eq to disodium edetate dihydrate) (6400000315) 0.050gm; malic acid l- (9600017802) 1.006gm; sodium hydroxide (9600028200) 0.200gm - 不能攝取適當食物之患者之補助治療劑，蛋白質之消化吸收機能或合成利障礙，嚴重傷火傷骨折時蛋白質之補給，蛋白質攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708) - pemetrexed disodium heptahydrate;;pemetrexed disodium heptahydrate - 凍晶注射劑 - pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium hemipentahydrate (equivalent to pemetrexed.....100mg)mg; pemetrexed disodium heptahydrate (1004002410) pemetrexed disodium hemipentahydrate (equivalent to pemetrexed.....500mg)mg - pemetrexed - 1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.單一藥物是局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣諾華股份有限公司 台北市中正區仁愛路二段99號11、12、13樓 (01516589) - disodium pamidronate;;disodium pamidronate - 凍晶注射劑 - disodium pamidronate (9200050110) mg; disodium pamidronate (9200050110) mg - pamidronic acid - 惡性腫瘤之蝕骨性骨頭轉移、惡性高血鈣症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708) - disodium pamidronate - 注射劑 - disodium pamidronate (9200050110) mg - pamidronic acid - 惡性腫瘤之蝕骨性骨頭轉移、惡性高血鈣症。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

岱億生物科技股份有限公司 臺北市內湖區民權東路六段180巷6號10樓之28 (80500870) - disodium pamidronate;;disodium pamidronate - 凍晶注射劑 - disodium pamidronate (9200050110) mg; disodium pamidronate (9200050110) mg - pamidronic acid - 惡性腫瘤之蝕骨性骨頭轉移、惡性高血鈣症。